Shares of Indevus Pharmaceuticals Inc. soared 73.6 percent Tuesday after the Lexington, Mass.-based company said it was being acquired by Endo Pharmaceuticals Holdings Inc. for $4.50 per share, or about $370 million in cash. (BioWorld Today) Read More
